Lenabasum for Systemic Sclerosis - Are Cannabinoids the Missing Link?

We read with great interest the results of the trial of lenabasum in SSc. After many recent failed studies, we are excited to come across a positive drug trial in SSc. However, the systemic manifestations of the subjects i.e. pulmonary manifestations such as PH and ILD deserve a more detailed analysis, including their treatment response.